{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T18:50:21Z","timestamp":1767034221197},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1038\/ncpuro0034","type":"journal-article","created":{"date-parts":[[2004,11,11]],"date-time":"2004-11-11T11:31:35Z","timestamp":1100172695000},"page":"31-37","source":"Crossref","is-referenced-by-count":18,"title":["Botulinum toxin in urology: evaluation using an evidence-based medicine approach"],"prefix":"10.1038","volume":"1","author":[{"given":"Christopher P","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George T","family":"Somogyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy B","family":"Boone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncpuro0034_CR1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","volume":"20","author":"WF Stewart","year":"2003","unstructured":"Stewart WF et al. (2003) Prevalence and burden of overactive bladder in the Unites States. World J Urol 20: 327\u2013336","journal-title":"World J Urol"},{"key":"BFncpuro0034_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/106002809603001011","volume":"30","author":"EM Perfetto","year":"1996","unstructured":"Perfetto EM and Morris LS (1996) Agency for Health Care Policy and Research clinical practice guidelines. Ann Pharmacother 30: 117\u2013121","journal-title":"Ann Pharmacother"},{"key":"BFncpuro0034_CR3","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1097\/01.ju.0000127725.48479.89","volume":"171","author":"CP Smith","year":"2004","unstructured":"Smith CP and Chancellor MB (2004) Emerging role of botulinum toxin in the management of voiding dysfunction. J Urol 171: 2128\u20132137","journal-title":"J Urol"},{"key":"BFncpuro0034_CR4","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0022-5347(17)42717-0","volume":"139","author":"DD Dykstra","year":"1988","unstructured":"Dykstra DD et al. (1988) Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol 139: 919","journal-title":"J Urol"},{"key":"BFncpuro0034_CR5","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s004670100055","volume":"16","author":"V Mall","year":"2001","unstructured":"Mall V et al. (2001) Treatment of neuropathic bladder using botulinum toxin A in a 1-year old child with myelomeningocele. Pediatr Nephrol 16: 1161\u20131162","journal-title":"Pediatr Nephrol"},{"key":"BFncpuro0034_CR6","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1097\/01.ju.0000091281.50081.f0","volume":"170","author":"HC Kuo","year":"2003","unstructured":"Kuo HC (2003) Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction. J Urol 170: 1908\u20131912","journal-title":"J Urol"},{"key":"BFncpuro0034_CR7","first-page":"24","volume":"71","author":"DD Dykstra","year":"1990","unstructured":"Dykstra DD and Sidi A (1990) Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double blind study. Arch Phys Med Rehabil 71: 24\u201326","journal-title":"Arch Phys Med Rehabil"},{"key":"BFncpuro0034_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/sj.sc.3100517","volume":"36","author":"H Petit","year":"1998","unstructured":"Petit H et al. (1998) Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease. Spinal Cord 36: 91\u201394","journal-title":"Spinal Cord"},{"key":"BFncpuro0034_CR9","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0022-5347(05)66438-5","volume":"165","author":"MW Phelan","year":"2001","unstructured":"Phelan MW et al. (2001) Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol 165: 1107\u20131110","journal-title":"J Urol"},{"key":"BFncpuro0034_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0302-2838(02)00209-9","volume":"42","author":"M De Seze","year":"2002","unstructured":"De Seze M et al. (2002) Botulinum A toxin and detrusor sphincter dyssynergia: A double-blind lidocaine-controlled study in 13 patients with spinal cord disease. Eur Urol 42: 56\u201362","journal-title":"Eur Urol"},{"key":"BFncpuro0034_CR11","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0022-5347(01)66376-6","volume":"155","author":"B Schurch","year":"1996","unstructured":"Schurch B et al. (1996) Botulinum A toxin as a treatment of detrusor-sphincter dyssynergia; a prospective study in 24 spinal cord injury patients. J Urol 155: 1023\u20131029","journal-title":"J Urol"},{"key":"BFncpuro0034_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0022-5347(17)54449-3","volume":"126","author":"EJ McGuire","year":"1981","unstructured":"McGuire EJ et al. (1981) The prognostic value of urodynamic testing in myelodysplastic patients. J Urol 126: 205\u2013209","journal-title":"J Urol"},{"key":"BFncpuro0034_CR13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0022-5347(01)63957-0","volume":"159","author":"YH Kim","year":"1998","unstructured":"Kim YH et al. (1998) Bladder leak point pressure: The measure for sphincterotomy success in spinal cord injured patients with external detrusor-sphincter dyssynergia. J Urol 159: 493\u2013496","journal-title":"J Urol"},{"key":"BFncpuro0034_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s192-002-8350-6","volume":"13","author":"CP Smith","year":"2002","unstructured":"Smith CP et al. (2002) Botulinum toxin urethral sphincter injection resolves urinary retention after pubovaginal sling operation. Int Urogynecol J Pelvic Floor Dysfunct 13: 185\u2013186","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"BFncpuro0034_CR15","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","volume":"164","author":"B Schurch","year":"2000","unstructured":"Schurch B et al. (2000) Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: A new alternative to anticholinergic drugs? Preliminary results. J Urol 164: 692\u2013697","journal-title":"J Urol"},{"key":"BFncpuro0034_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0302-2838(03)00136-2","volume":"44","author":"H Schulte-Baukloh","year":"2003","unstructured":"Schulte-Baukloh H et al. (2003) Botulinum A-toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder. Eur Urol 44: 139\u2013143","journal-title":"Eur Urol"},{"key":"BFncpuro0034_CR17","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1097\/01.ju.0000108892.35041.2d","volume":"171","author":"M Riccabona","year":"2004","unstructured":"Riccabona M et al. (2004) Botulinum-A toxin injection into the detrusor: A safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. J Urol 171: 845\u2013848","journal-title":"J Urol"},{"key":"BFncpuro0034_CR18","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1097\/01.ju.0000108407.53880.6a","volume":"171","author":"A Reitz","year":"2004","unstructured":"Reitz A and Schurch B (2004) Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity. J Urol 171: 804\u2013805","journal-title":"J Urol"},{"key":"BFncpuro0034_CR19","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/01.ju.0000108844.10235.f1","volume":"171","author":"D Pistolesi","year":"2004","unstructured":"Pistolesi D et al. (2004) Botulinum toxin type B for type A resistant bladder spasticity. J Urol 171: 802\u2013803","journal-title":"J Urol"},{"key":"BFncpuro0034_CR20","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s00192-003-1099-3","volume":"14","author":"D Dykstra","year":"2003","unstructured":"Dykstra D et al. (2003) Treatment of overactive bladder with botulinum toxin type B: a pilot study. Int Urogynecol J Pelvic Floor Dysfunct 14: 424\u2013426","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"BFncpuro0034_CR21","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.urology.2004.01.041","volume":"63","author":"DE Rapp","year":"2004","unstructured":"Rapp DE et al. (2004) Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: An initial experience. Urology 63: 1071\u20131075","journal-title":"Urology"},{"key":"BFncpuro0034_CR22","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","volume":"45","author":"A Reitz","year":"2004","unstructured":"Reitz A et al. (2004) European experience of 200 cases treated with Botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 45: 510\u2013515","journal-title":"Eur Urol"},{"key":"BFncpuro0034_CR23","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/01.ju.0000132152.53532.5d","volume":"172","author":"A Giannantoni","year":"2004","unstructured":"Giannantoni A et al. (2004) Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: A prospective randomized study. J Urol 172: 240\u2013243","journal-title":"J Urol"},{"key":"BFncpuro0034_CR24","doi-asserted-by":"crossref","unstructured":"Smith CP et al. Botulinum toxin A has antinociceptive effects in treating interstitial cystitis. Urology, in press","DOI":"10.1016\/j.urology.2004.06.073"},{"key":"BFncpuro0034_CR25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0090-4295(03)00477-1","volume":"62","author":"G Maria","year":"2003","unstructured":"Maria G, et al. (2003) Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: Results of a randomized, placebo-controlled study. Urology 62: 259\u2013264","journal-title":"Urology"},{"key":"BFncpuro0034_CR26","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S0003-9993(98)90050-8","volume":"79","author":"P Gallien","year":"1998","unstructured":"Gallien P et al. (1998) Treatment of detrusor sphincter dyssynergia by transperineal injection of botulinum toxin. Arch Phys Med Rehabil 79: 715\u2013717","journal-title":"Arch Phys Med Rehabil"}],"container-title":["Nature Clinical Practice Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0034.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0034","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0034.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T21:19:11Z","timestamp":1684444751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpuro0034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["BFncpuro0034"],"URL":"https:\/\/doi.org\/10.1038\/ncpuro0034","relation":{},"ISSN":["1743-4270","1743-4289"],"issn-type":[{"value":"1743-4270","type":"print"},{"value":"1743-4289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}